Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 2
1958 1
1961 1
1963 1
1965 1
1966 1
1971 1
1973 1
1974 3
1975 3
1976 5
1977 2
1978 3
1980 1
1981 2
1984 2
1986 2
1988 1
1989 1
1990 3
1991 3
1992 3
1993 1
1994 2
1995 3
1996 4
1997 4
1998 3
1999 1
2000 2
2001 3
2002 3
2003 3
2004 5
2005 18
2006 4
2007 12
2008 8
2009 9
2010 11
2011 22
2012 22
2013 24
2014 12
2015 20
2016 23
2017 26
2018 27
2019 22
2020 23
2021 40
2022 52
2023 7
Text availability
Article attribute
Article type
Publication date

Search Results

407 results
Results by year
Filters applied: . Clear all
Page 1
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.
Ott PA, Hu-Lieskovan S, Chmielowski B, Govindan R, Naing A, Bhardwaj N, Margolin K, Awad MM, Hellmann MD, Lin JJ, Friedlander T, Bushway ME, Balogh KN, Sciuto TE, Kohler V, Turnbull SJ, Besada R, Curran RR, Trapp B, Scherer J, Poran A, Harjanto D, Barthelme D, Ting YS, Dong JZ, Ware Y, Huang Y, Huang Z, Wanamaker A, Cleary LD, Moles MA, Manson K, Greshock J, Khondker ZS, Fritsch E, Rooney MS, DeMario M, Gaynor RB, Srinivasan L. Ott PA, et al. Among authors: ting ys. Cell. 2020 Oct 15;183(2):347-362.e24. doi: 10.1016/j.cell.2020.08.053. Cell. 2020. PMID: 33064988 Free article. Clinical Trial.
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction.
Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, Chhangawala S, Rubinsteyn A, Hammerbacher J, Gaynor RB, Fritsch EF, Greshock J, Oslund RC, Barthelme D, Addona TA, Arieta CM, Rooney MS. Abelin JG, et al. Among authors: ting ys. Immunity. 2019 Oct 15;51(4):766-779.e17. doi: 10.1016/j.immuni.2019.08.012. Epub 2019 Sep 5. Immunity. 2019. PMID: 31495665 Free article.
Glutathione Supplementation as an Adjunctive Therapy in COVID-19.
Guloyan V, Oganesian B, Baghdasaryan N, Yeh C, Singh M, Guilford F, Ting YS, Venketaraman V. Guloyan V, et al. Among authors: ting ys. Antioxidants (Basel). 2020 Sep 25;9(10):914. doi: 10.3390/antiox9100914. Antioxidants (Basel). 2020. PMID: 32992775 Free PMC article. Review.
A pedunculated mass of the thigh.
Ong CYG, Teo RM, Ting Y. Ong CYG, et al. Among authors: ting y. Ann Acad Med Singap. 2021 Nov;50(11):871-873. doi: 10.47102/annals-acadmedsg.2021165. Ann Acad Med Singap. 2021. PMID: 34877595 Free article. No abstract available.
Heterologous Immunity Between SARS-CoV-2 and Pathogenic Bacteria.
Eggenhuizen PJ, Ng BH, Chang J, Cheong RMY, Yellapragada A, Wong WY, Ting YT, Monk JA, Gan PY, Holdsworth SR, Ooi JD. Eggenhuizen PJ, et al. Among authors: ting yt. Front Immunol. 2022 Jan 27;13:821595. doi: 10.3389/fimmu.2022.821595. eCollection 2022. Front Immunol. 2022. PMID: 35154139 Free PMC article.
Primary lung cancer in the azygos lobe.
Ting YC, Chuang LC, Hsu PK. Ting YC, et al. Eur J Cardiothorac Surg. 2021 Jun 14;59(6):1351. doi: 10.1093/ejcts/ezab085. Eur J Cardiothorac Surg. 2021. PMID: 33624029 No abstract available.
Small cell neuroendocrine carcinoma of the gallbladder.
Ting YY, John A, Maddern G, Kuan LL. Ting YY, et al. ANZ J Surg. 2021 May;91(5):E357-E359. doi: 10.1111/ans.16366. Epub 2020 Oct 4. ANZ J Surg. 2021. PMID: 33012064 No abstract available.
407 results